Skip to main content

Table 7 Non-traditional treatment usage by seizure group.

From: Traditional and non-traditional treatments for autism spectrum disorder with seizures: an on-line survey

Treatment Overall Controls Clinical Seizures Subclinical Seizures
Supplement treatments
Vitamin B12 24% 32% 20% 26% ns,ns
L-Carnitine/Acetyl-L-Carnitine 21% 22% 18% ns 29% ns,ns
Magnesium 20% 26% 17% ns 22% ns,ns
Coenzyme Q10 14% 16% 12% ns 15% ns,ns
Glutathione 14% 14% 12% ns 18% ns,ns
Dimethylglycine 11% 14% 9% ns 13% ns,ns
Taurine 11% 10% 10% ns 14% ns,ns
GABA 9% 12% 8% ns 9% ns,ns
5-Hydroxytryptophan 8% 11% 6%ns 9% ns,ns
L-Carnosine 6% 5% 5% ns 10%ns,ns
Drug treatments
Chelation Therapy 12% 15% 10%ns 16% ns,ns
Hyperbaric Oxygen Therapy 7% 6% 7% ns 10% ns,ns
Dietary treatments
Gluten Free Casein Free Diet 31% 41% 25% 31%ns,ns
Specific Carbohydrate Diet 6% 4% 6% ns 8% ns,ns
Atkins or Modified Atkins Diet 2% 1% 3% ns 2% ns,ns
  1. ‡p < = 0.001; †p < = 0.0001
  2. For each treatment listed, statistical comparisons were made between the clinical seizure group and the control group (superscript after the clinical seizure percentage), the subclinical seizure group and the control group (1st superscript after the subclinical seizure percentage) and between the clinical and subclinical seizure group (2nd superscript after the subclinical seizure percentage). There are 15 treatments and 3 comparisons for each treatments resulting in 45 comparisons. The Bonferroni correction results in an alpha of 0.05/45 = 0.0011, so we have set the alpha to p < = 0.001 to be conservative.